Eris Lifesciences Q2 Results
- BSE: 540596
- NSE: ERIS
- ISIN: INE406M01024
- Sector: Biotechnology & Drugs
BSE
1,757.95
-16.35 (-0.92%)
-16.35 (-0.92%)Volume1.25 K
Updated: Fri 18 Jul, 2025 | 15:29:00
NSE
1,767.00-9.30 (-0.52%)
-9.30 (-0.52%)Volume80.55 K
Updated: Fri 18 Jul, 2025 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Eris Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 557.14 | 545.67 | 2.10% |
| Depreciation/ Amortization | 80.48 | 75.94 | 5.98% |
| Operating Income | 184.03 | 174.05 | 5.73% |
| Net Income | 91.59 | 83.18 | 10.11% |
| Other Operating Expenses Total | 164.76 | 156.52 | 5.26% |
| Net Income Before Taxes | 129.11 | 115.32 | 11.96% |
| Total Revenue | 741.17 | 719.72 | 2.98% |
| Selling/ General/ Admin Expenses Total | 125.63 | 132.62 | -5.27% |
| Diluted Normalized EPS | 6.72 | 6.10 | 10.16% |